Patents by Inventor Nadimpally Neha Varma

Nadimpally Neha Varma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Viral infection treatment with 5-aminolevulinic acid
    Patent number: 11883376
    Abstract: A method for amelioriation of, or prophylaxis against, a viral infection comprising administering to a patient in need of treatment a therapeutically effective amount of 5 aminolevulinic acid, optionally with at least one of cucumarin nano, zinc, vitamin C and methylene blue, and compositions thereof. Such compositions may be used for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses.
    Type: Grant
    Filed: June 6, 2021
    Date of Patent: January 30, 2024
    Inventors: Nadimpally Satyavarahala Raju, Venkata Satya Suresh Attili, Nadimpally Neha Varma, Steven Jerome Moore, Cullen Thomas Moore
  • VIRAL INFECTION TREATMENT WITH 5-AMINOLEVULINIC ACID
    Publication number: 20210330622
    Abstract: A method for amelioriation of, or prophylaxis against, a viral infection comprising administering to a patient in need of treatment a therapeutically effective amount of 5 aminolevulinic acid, optionally with at least one of cucumarin nano, zinc, vitamin C and methylene blue, and compositions thereof. Such compositions may be used for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses.
    Type: Application
    Filed: June 6, 2021
    Publication date: October 28, 2021
    Inventors: Nadimpally Satyavarahala Raju, Venkata Satya Suresh Attili, Nadimpally Neha Varma, Steven Jerome Moore, Cullen Thomas Moore
  • Therapy for viral infections including the novel corona virus (COVID-19)
    Patent number: 11026909
    Abstract: A method for amelioriation of, or prophylaxis against, a viral infection comprising administering to a patient in need of treatment a therapeutically effective amount of 5 aminolevulinic acid, optionally with at least one of cucumarin nano, zinc, vitamin C and methylene blue, and compositions thereof. Such compositions may be used for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: June 8, 2021
    Inventors: Nadimpally Satyavarahala Raju, Venkata Satya Suresh Attili, Nadimpally Neha Varma, Steven Jerome Moore, Cullen Thomas Moore
  • Combination therapy for coronavirus infections including the novel corona virus (COVID-19)
    Patent number: 10987329
    Abstract: The present invention provides therapeutic combinations of 5-aminolevulinic acid, with at least one of: Vitamin C, curcumin, zinc, and methylene blue for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses. Optionally such compositions may comprise other dietary supplements and one or more pharmaceutically acceptable excipients and also process for preparing it. The composition can also include other antiviral agents.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: April 27, 2021
    Inventors: Nadimpally Satyavarahala Raju, Venkata Satya Suresh Attili, Nadimpally Neha Varma, Steven Jerome Moore, Cullen Thomas Moore